Archi Agarwal

580 total citations · 1 hit paper
15 papers, 260 citations indexed

About

Archi Agarwal is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Archi Agarwal has authored 15 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Archi Agarwal's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Archi Agarwal is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Archi Agarwal collaborates with scholars based in India, United Kingdom and United States. Archi Agarwal's co-authors include Venkatesh Rangarajan, Ganesh Bakshi, Gagan Prakash, Palak Popat, Kumar Prabhash, Mahendra Pal, Priyamvada Maitre, Rahul Krishnatry, Vanita Noronha and Vedang Murthy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Archi Agarwal

13 papers receiving 259 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

2021 176 citations Vedang Murthy, Priyamvada Maitre et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Archi Agarwal India	6	198	98	50	41	30	15	260
John Dombrowski United States	6	249 1.3×	191 1.9×	46 0.9×	32 0.8×	32 1.1×	11	302
P. Graff-Cailleaud France	6	186 0.9×	62 0.6×	60 1.2×	20 0.5×	21 0.7×	14	224
Chiara Lucrezia Deantoni Italy	9	173 0.9×	119 1.2×	49 1.0×	83 2.0×	49 1.6×	29	273
Moses Arunsingh India	11	136 0.7×	89 0.9×	44 0.9×	64 1.6×	32 1.1×	42	228
O. Gilliot France	5	180 0.9×	57 0.6×	48 1.0×	46 1.1×	24 0.8×	11	247
Sabine Meersschout Belgium	5	243 1.2×	150 1.5×	32 0.6×	121 3.0×	37 1.2×	6	310
Giorgia Timon Italy	8	110 0.6×	54 0.6×	38 0.8×	68 1.7×	34 1.1×	24	170
B. Noris Chiorda Italy	5	150 0.8×	86 0.9×	45 0.9×	38 0.9×	55 1.8×	18	218
Feisal Bunkheila Italy	7	115 0.6×	73 0.7×	41 0.8×	116 2.8×	31 1.0×	14	256
Soon Huh United States	10	243 1.2×	166 1.7×	57 1.1×	40 1.0×	94 3.1×	20	325

Countries citing papers authored by Archi Agarwal

Since Specialization

Citations

This map shows the geographic impact of Archi Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archi Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archi Agarwal more than expected).

Fields of papers citing papers by Archi Agarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archi Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archi Agarwal. The network helps show where Archi Agarwal may publish in the future.

Co-authorship network of co-authors of Archi Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Archi Agarwal. A scholar is included among the top collaborators of Archi Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archi Agarwal. Archi Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sengar, Manju, Akhil Kapoor, Ajay Singh, et al.. (2023). A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/−R) Regimen. Indian Journal of Hematology and Blood Transfusion. 40(1). 36–42.

Sengar, Manju, Hasmukh Jain, Tanuja Shet, et al.. (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)‐associated lymphomas. British Journal of Haematology. 200(4). 429–439. 1 indexed citations

Jain, Hasmukh, Akhil Kapoor, Manju Sengar, et al.. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 37(3). 379–385. 3 indexed citations

Kazi, Mufaddal, et al.. (2021). Elevated CEA with negative PET scan on surveillance of colorectal cancers—a role of CEA kinetics. Langenbeck s Archives of Surgery. 407(2). 769–778. 3 indexed citations

Murthy, Vedang, Priyamvada Maitre, Sadhana Kannan, et al.. (2021). Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 39(11). 1234–1242. 176 indexed citations breakdown →

Murthy, Vedang, et al.. (2020). Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI. Nuclear Medicine Communications. 41(12). 1291–1298. 4 indexed citations

Mallick, Indranil, Shwetabh Sinha, Rahul Krishnatry, et al.. (2020). Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL). BMJ Open. 10(2). e034623–e034623. 19 indexed citations

Patil, Vijay, Vanita Noronha, Shivakumar Thiagarajan, et al.. (2020). Salvage surgery in head and neck cancer: Does it improve outcomes?. European Journal of Surgical Oncology. 46(6). 1052–1058. 25 indexed citations

Bakshi, Ganesh, et al.. (2020). Thyroid-Like Follicular Carcinoma of the Kidney With Low-Grade Sarcomatoid Component: A Hitherto Undescribed Case. International Journal of Surgical Pathology. 29(3). 327–333. 6 indexed citations

10.

Joshi, Amit, Vanita Noronha, Nilesh Sable, et al.. (2019). A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer. South Asian Journal of Cancer. 9(1). 23–26. 1 indexed citations

11.

Murthy, Vedang, et al.. (2019). 68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancer. Nuclear Medicine Communications. 40(12). 1283–1288. 5 indexed citations

12.

Rekhi, Bharat & Archi Agarwal. (2017). Cytopathologic features of an unusual case of multiple eccrine spiradenomas misdiagnosed as a malignant round cell tumor. Journal of Cytology. 34(1). 39–39. 9 indexed citations

13.

Chopra, Supriya, Reena Engineer, Shaesta Mehta, et al.. (2017). Protocol for a phase III randomized trial of chemoradiation and systemic chemotherapy vs. systemic chemotherapy alone in patients with unresectable nonmetastatic cholangiocarcinoma. International Journal of Clinical Trials. 4(1). 14–14.

14.

Jain, Hasmukh, Manju Sengar, Hari Menon, et al.. (2016). A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen. Blood. 128(22). 4213–4213. 1 indexed citations

15.

Purandare, Nilendu, et al.. (2012). Role of Delayed Imaging to Differentiate Intense Physiological 18F FDG Uptake From Peritoneal Deposits in Patients Presenting With Intestinal Obstruction. Clinical Nuclear Medicine. 37(8). 783–785. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact